Northwestern Mutual Wealth Management’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
Other funds holding SAGE
MAP
AAM
6CM
Northwestern Mutual Wealth Management's SAGE Position: Q2 2025 in Review
Northwestern Mutual Wealth Management sold out of Sage Therapeutics (SAGE) in Q2 2025, closing a stake of 250 shares — an estimated $1.99K sold.
Northwestern Mutual Wealth Management first reported a position in SAGE in Q2 2016 and held it in 22 quarters. The position peaked at $8K in Q4 2021. 192 funds tracked by Wall St. Rank hold SAGE as of Q2 2025.
- Northwestern Mutual Wealth Management reported no remaining Sage Therapeutics position as of Q2 2025 after selling out during the quarter.
- Northwestern Mutual Wealth Management sold 250 Sage Therapeutics shares in Q2 2025, an estimated $1.99K.
- Northwestern Mutual Wealth Management first reported a position in Sage Therapeutics in Q2 2016 and held it in 22 quarters.
- Northwestern Mutual Wealth Management's Sage Therapeutics position peaked at $8K in Q4 2021.
- 192 funds tracked by Wall St. Rank held Sage Therapeutics as of Q2 2025.
Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2025, filed 13 Aug 2025.